Medistim ASA (MEDI)

Currency in NOK
246.00
+13.00(+5.58%)
Closed·
Advertisement
Unusual trading volume
MEDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
240.00250.00
52 wk Range
186.50292.00
Key Statistics
Prev. Close
233
Open
243
Day's Range
240-250
52 wk Range
186.5-292
Volume
97.66K
Average Volume (3m)
21.2K
1-Year Change
-6.4639%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
325.00
Upside
+32.11%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 22 consecutive years

Medistim ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 325.00
(+32.11% Upside)

Medistim ASA Earnings Call Summary for Q2/2026

  • Medistim reported record Q2 2026 revenue of 202M NOK (up 27.5% currency-neutral) and EBIT of 65.3M NOK with 32.3% margin; shares rose 5.6% to $246.
  • First-half revenue exceeded 400M NOK for first time; Americas led growth at 46.3% currency-neutral, driven by pricing (37%) and volume gains (9%).
  • Management expects higher growth trajectory than past five years with continued margin expansion; targeting 1B NOK annual revenue within 'couple of years.'
  • New product launches planned for Q2 2027 including MiraQ Ultimate and Vascular systems; INTUI software expansion scheduled for H1 2027.
  • Board authorized quarterly dividends going forward, extending 22-year payment streak; tariff costs of 5M NOK in Q2 offset by strong pricing power.
Last Updated: 21/08/2026, 09:00
Read Full Transcript

Earnings

Latest Release
21/08/2026
EPS / Forecast
2.66 / --
Revenue / Forecast
202M / 176M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.54%
Dividend Yield
3.43%
Industry Median 3.30%
Annualised payout
8.00
Paid annually
5-Years Growth
+21.67%
Growth Streak

Compare MEDI to Peers and Sector

Metrics to compare
MEDI
Peers
Sector
Relationship
P/E Ratio
-17.4x−0.4x
PEG Ratio
-0.310.00
Price/Book
-2.9x2.6x
Price / LTM Sales
-2.6x3.1x
Upside (Analyst Target)
32.1%31.9%48.9%
Fair Value Upside
Unlock17.4%6.2%Unlock

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Employees
159
Market
Norway

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.73M31.34%1.41B
Other Institutional Investors
12.15M66.41%2.99B
Public Companies & Retail Investors
411.21K2.25%101.16M
Total
18.29M100.00%4.5B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Intertrade Shipping AS12.57%2,300,001565,800
Danske Capital Denmark9.97%1,824,460448,817

People Also Watch

22.65
LECS
+0.22%
10.000
AZK
-0.50%
80.600
CEMB
+0.62%
63.00
GFII
-1.25%
7.90
GRBT
+1.94%

FAQ

What Is the Medistim (Oslo: MEDI) Share Price Today?

The Medistim stock price today is 246.00 NOK.

What Stock Exchange Does Medistim (MEDI) Trade On?

Medistim is listed and trades on the Oslo Stock Exchange.

What Is the Ticker (Stock Symbol) for Medistim?

The stock symbol (also called a 'ticker') for Medistim is "MEDI."

Does Medistim Pay Dividends? What’s The Current MEDI Dividend Yield?

Yes, MEDI Pays Dividends to its Shareholders. The current Medistim dividend yield is 3.43%.

What Is the Current Medistim Market Capitalisation?

As of today, Medistim (Oslo: MEDI) market cap is 4.50B NOK.

What Is Medistim's (MEDI) Earnings Per Share (TTM)?

The Medistim EPS is currently 8.54 (Trailing Twelve Months).

When Is the Next Medistim Earnings Date?

Medistim's next earnings report will be released on 23/10/2026.

Is MEDI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medistim moving averages and other technical indicators, the daily buy/sell signal for MEDI stock is Strong Buy.

How Many Times Has Medistim Stock Split?

Medistim has split 0 times. (See the MEDI stock split history page for full effective split date and price information.)

How Many Employees Does Medistim Have?

Medistim has 159 employees, based on their latest Companies House report.

What is the current trading status of Medistim (Oslo: MEDI)?

As of 23/08/2026, Medistim (MEDI) is trading at a share price of 246.00 NOK, with a previous close of 233.00 NOK. The stock has fluctuated within a day range of 240.00 NOK to 250.00 NOK, while its 52-week range spans from 186.50 NOK to 292.00 NOK.

What Is Medistim (MEDI) Price Target According to Analysts?

The average 12-month price target for Medistim is 325.00 NOK, with a high estimate of 340 NOK and a low estimate of 310 NOK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32.11% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.